Minerva Neurosciences Inc
F:4MNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Minerva Neurosciences Inc
F:4MNA
|
US |
|
B
|
Bayer AG
F:BAYA
|
DE |
|
Petrofac Ltd
F:P2F0
|
JE |
|
Dai Nippon Printing Co Ltd
F:DNP0
|
JP |
|
Target Hospitality Corp
NASDAQ:TH
|
US |
|
C
|
Carnival PLC
F:POH1
|
UK |
|
S
|
Seabridge Gold Inc
F:SRM
|
CA |
|
C
|
Chalice Mining Ltd
SWB:C8U
|
AU |
|
C
|
Champion Iron Ltd
F:MMPI
|
AU |
|
C
|
Cognex Corp
F:CGZ
|
US |
|
Jollibee Foods Corp
OTC:JBFCF
|
PH |
|
C
|
Canadian Natural Resources Ltd
XMUN:CRC
|
CA |
|
C
|
Clinuvel Pharmaceuticals Ltd
XMUN:UR9
|
AU |
|
J
|
Japan Post Bank Co Ltd
SWB:5JP
|
JP |
|
V
|
Viatris Inc
DUS:VIA
|
US |
|
P
|
Petrofac Ltd
F:P2F
|
JE |
|
V
|
voestalpine AG
DUS:VAS
|
AT |
|
Chalice Mining Ltd
ASX:CHN
|
AU |
|
Lenovo Group Ltd
HKEX:992
|
CN |
|
Mitsubishi Gas Chemical Co Inc
OTC:MBGCF
|
JP |
|
C
|
C&C Group PLC
OTC:CCGPY
|
IE |
Bankruptcy Probability
Minerva Neurosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Minerva Neurosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Minerva Neurosciences Inc
NASDAQ:NERV
|
230.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Minerva Neurosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Minerva Neurosciences Inc has total debt of 60m USD. This includes both short-term (0 USD) and long-term (60m USD) debt.
You can find a full breakdown on its Balance Sheet.
